An extended programme of both in vitro, ex-vivo and in vivo studies has been under way at the Manchester Institute of Biotechnology under the jurisdiction of Professor McGrouther and Mr Ardeshir Bayat and their scientific teams in cooperation with the Fenzian clinical team.
Sophisticated cellular in vitro models have been created de novo to help challenge the Fenzian modus operandi.
Already a series of papers have been produced and published in a growing programme of studies to continue growth in applications and improvements of the Fenzian Treatment System.
“I had horrible pain in my face which disrupted my life. It was described as trigeminal neuralgia. To my huge delight, it went after Fenzian treatment.”
Atypical facial pain - June